FelineLeukemiaVirusSuggested Articles LymphomaFelineVaccines: Benefits and Risks Diarrhea Neurological DisordersFelineVision Problems: A Host of Possible CausesFelineleukemiavirus(FeLV) is one of the most common and important infectious diseases in cats, affecting between 2-3% of all cats in the United States and Canada.
Felineleukemiavirus(FeLV) is one of the most important viruses infecting cats. FeLV tends to become a persistent infection and depresses the immune system of cats. FeLV is an important cause of anemia in cats and can cause cancers of several types. For further details on this important disease, see our handout
FelineLeukemia(FeLV)vaccinesare licensed to stimulate immunity to FeLV in cats. Various formulations are available, including inactivated, wholevirusvaccines, recombinant subunitvaccines; and genetically-engineered, subunit recombinantvaccineslinked with a canary pox vectorvirus.
AAFPFelineVaccination Advisory Panel recommendations forfelineleukemiavirusvaccination100 Initial vaccination protocol for kittens and unvaccinated adult cats Administer FeLVvaccineseries to all cats at risk of infection and all kittens up to and including 1 year of age Test all cats for retrovirus infection
FelineLeukemiais a preventable disease in household cats, through vaccination and reduction of risk factors in their environment. Learn more here...
Such details provide a deeper understanding and appreciation for Feline Leukemia Virus Vaccine Information.
Vanguard ®FelineFeLV (FeLVvaccine) For vaccination of healthy cats 9 weeks of age or older againstfelineleukemiavirus.
PUREVAX ® Recombinant FeLV contains a nonadjuvanted lyophilized suspension of a recombinant vectoredfelineleukemiavaccineplus sterile water diluent. A canarypox vector has been modified using recombinant technology to produce expression of desired antigens capable of stimulating a protective immune response tofelineleukemia. Safety and immunogenicity of this product have been ...
